
Genenta Science S.p.A. (SAEN) Stock Overview
Explore Genenta Science S.p.A.’s financial performance, market position, analyst ratings, and future outlook.
Genenta Science S.p.A. (SAEN)
Key Financials
Key Financials
Market Cap
24.1M
P/E Ratio
-1.40
EPS (TTM)
N/A
ROE
-0.37%
SAEN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Genenta Science S.p.A. (NASDAQ: SAEN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Genenta Science S.p.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SAEN on the NASDAQ shows an RSI of 20.74, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.
Key metrics behind Genenta Science S.p.A.'s NASDAQ-traded stock include a P/E ratio of -1.40 and a market capitalization of 24.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SAEN on the NASDAQ.